SCHEMBL806515

SCHEMBL806515

Cc1ccc2cc(C)c(CO)cc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 5/20 0.52
CYP1A2 P05177 5/20 0.52
TDP1 Q9NUW8 2/20 0.45
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 3/20 0.39
HSD17B10 Q99714 2/20 0.39
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
SHBG P04278 1/20 0.37
KMT2A Q03164 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TP53 P04637 1/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17208935 0.82 CYP2A6 (0.50) CYP2A6CYP1A2TDP1PDE4APDE4B
SCHEMBL8313745 0.81 MEN1 (0.46) CYP2A6CYP1A2TDP1PDE4APDE4B
SCHEMBL14472704 0.81 CYP2A6 (0.42) CYP2A6TDP1PDE4APDE4BPDE4C
SCHEMBL14472634 0.81 CYP2A6 (0.42) CYP2A6TDP1PDE4APDE4BPDE4C
SCHEMBL14733994 0.79 CYP2A6 (0.42) CYP2A6CYP1A2TDP1KDM4EALDH1A1
SCHEMBL806312 0.78 PDE4A (0.61) CYP2A6CYP1A2TDP1PDE4APDE4B
SCHEMBL606287 0.78 CYP1A2 (0.77) CYP2A6CYP1A2TDP1KDM4EALDH1A1
SCHEMBL29595072 0.78 CYP1A2 (0.77) CYP2A6CYP1A2TDP1KDM4EALDH1A1
SCHEMBL92914 0.76 TAAR1 (0.56) TDP1KDM4EALDH1A1GAAHPGD
SCHEMBL95787 0.76 TP53 (0.48) TDP1KDM4EALDH1A1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012036253-A1 HETEROCYCLIC COMPOUNDS FOR TREATING OR PREVENTING DISORDERS CAUSED BY REDUCED NEUROTRANSMISSION OF SEROTONIN, NOREPHNEPHRINE OR DOPAMINE. OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2012-03-22 WO disclosed